CLEC10A and neoplasm: The preliminary analysis of the surface inhibitory receptors of DCs showed that several receptors, including B7H3, Tim3, CD31, and OX2, were increased in tumour-induced DCs (Supplementary Table S4), with a decrease in CD301, FcγRIIA, DCIR, ILT4, and Tyro3.